Voloridge Investment Management Portfolio holdings
AUM
$27.1B
1-Year Return
25.54%
This Quarter Return
+4.58%
1 Year Return
+25.54%
3 Year Return
+79.26%
5 Year Return
+135.5%
10 Year Return
+413.11%
AUM
$18.3B
AUM Growth
+$2.74B
(+18%)
Cap. Flow
+$2.24B
Cap. Flow
% of AUM
12.26%
Top 10 Holdings %
Top 10 Hldgs %
8.78%
Holding
1,974
New
365
Increased
607
Reduced
559
Closed
443
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$404M |
| 2 |
Honeywell
HON
|
+$154M |
| 3 |
Snap
SNAP
|
+$123M |
| 4 |
Citigroup
C
|
+$118M |
| 5 |
Mercado Libre
MELI
|
+$112M |
Top Sells
| 1 |
Micron Technology
MU
|
+$161M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$127M |
| 3 |
Verizon
VZ
|
+$121M |
| 4 |
Elevance Health
ELV
|
+$108M |
| 5 |
Freeport-McMoran
FCX
|
+$93.5M |
Sector Composition
| 1 | Technology | 17.97% |
| 2 | Consumer Discretionary | 13.57% |
| 3 | Industrials | 13.36% |
| 4 | Financials | 12.69% |
| 5 | Healthcare | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
851
NovoCure
NVCR
$1.4B
| $3.49M | 0.02% |
+46,518
| New | +$3.49M |
|
852
Mr. Cooper
COOP
$14.7B
| $3.49M | 0.02% |
83,926
-33,886
| -29% | -$1.41M |
|
853
Sabre
SABR
$722M
| $3.49M | 0.02% |
406,202
-1,398,821
| -77% | -$12M |
|
|
CDMO
854
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $3.49M | 0.02% |
119,583
-36,760
| -24% | -$1.07M |
|
855
CNO Financial Group
CNO
$3.79B
| $3.49M | 0.02% |
146,201
+57,399
| +65% | +$1.37M |
|
856
Hormel Foods
HRL
$13.9B
| $3.48M | 0.02% |
71,301
-24,551
| -26% | -$1.2M |
|
857
VeriSign
VRSN
$26.7B
| $3.48M | 0.02% |
+13,700
| New | +$3.48M |
|
858
Amcor
AMCR
$19.1B
| $3.47M | 0.02% |
288,929
-40,532
| -12% | -$487K |
|
859
Mine Safety
MSA
$6.75B
| $3.45M | 0.02% |
22,878
-4,142
| -15% | -$625K |
|
860
Cogent Communications
CCOI
$1.76B
| $3.45M | 0.02% |
47,128
+30,158
| +178% | +$2.21M |
|
861
First Bancorp
FBP
$3.52B
| $3.45M | 0.02% |
250,291
+186,361
| +292% | +$2.57M |
|
862
Murphy USA
MUSA
$7.5B
| $3.45M | 0.02% |
17,305
-12,870
| -43% | -$2.56M |
|
|
VNE
863
DELISTED
Veoneer, Inc.
VNE
| $3.44M | 0.02% |
97,040
-104,415
| -52% | -$3.7M |
|
864
Astrana Health
ASTH
$1.4B
| $3.44M | 0.02% |
46,796
-86,663
| -65% | -$6.37M |
|
865
Vicor
VICR
$2.29B
| $3.43M | 0.02% |
26,992
+21,831
| +423% | +$2.77M |
|
|
ZY
866
DELISTED
Zymergen Inc. Common Stock
ZY
| $3.42M | 0.02% |
+510,920
| New | +$3.42M |
|
867
Enanta Pharmaceuticals
ENTA
$186M
| $3.4M | 0.02% |
45,483
+33,319
| +274% | +$2.49M |
|
868
Ultra Clean Holdings
UCTT
$1.16B
| $3.39M | 0.02% |
59,083
-29,001
| -33% | -$1.66M |
|
869
Capri Holdings
CPRI
$2.52B
| $3.39M | 0.02% |
52,174
+35,899
| +221% | +$2.33M |
|
870
CF Industries
CF
$14.1B
| $3.39M | 0.02% |
47,824
-190,700
| -80% | -$13.5M |
|
871
Patterson-UTI
PTEN
$2.14B
| $3.37M | 0.02% |
399,323
+2,702
| +0.7% | +$22.8K |
|
872
Exact Sciences
EXAS
$10.5B
| $3.37M | 0.02% |
+43,340
| New | +$3.37M |
|
873
Haemonetics
HAE
$2.58B
| $3.36M | 0.02% |
63,429
-49,501
| -44% | -$2.63M |
|
|
NVTA
874
DELISTED
Invitae Corporation
NVTA
| $3.36M | 0.02% |
220,321
+167,428
| +317% | +$2.56M |
|
875
Moelis & Co
MC
$5.57B
| $3.35M | 0.02% |
+53,556
| New | +$3.35M |
|